Emergent BioSolutions
EBS
#8443
Rank
C$0.42 B
Marketcap
C$8.29
Share price
5.85%
Change (1 day)
-30.97%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): C$83.12 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.64 Billion. In 2025 the company made an earning of C$0.19 Billion, an increase over its 2024 earnings that were of -C$99.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$83.12 M-57.85%
2025 C$0.19 B-297.64%
2024 -C$99.8 Million-88.82%
2023 -C$0.9 Billion242.73%
2022 -C$0.27 Billion-153.8%
2021 C$0.48 B-20.43%
2020 C$0.60 B278.02%
2019 C$0.16 B27.11%
2018 C$0.12 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.14 B0.45%
2015 C$0.14 B73.51%
2014 C$85.08 M41.36%
2013 C$60.18 M35.2%
2012 C$44.51 M0.4%
2011 C$44.34 M-56.46%
2010 C$0.10 B76.73%
2009 C$57.62 M32.94%
2008 C$43.34 M-5.62%
2007 C$45.92 M
2005 C$66.49 M269.89%
2004 C$17.97 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.69 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.25 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.89 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$16.25 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$28.64 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.43 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.15 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel